Current Cancer Drug Targets

Journal Abbreviation: CURR CANCER DRUG TAR
Journal ISSN: 1568-0096

About Current Cancer Drug Targets

    Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.<br/><br/>Current Cancer Drug Targets publishes original research articles and a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.<br/><br/>As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
Year Impact Factor (IF) Total Articles Total Cites
2022 (2023 update) 3.0 - 3540
2021 2.907 - 3861
2020 3.428 73 3578
2019 2.912 77 3032
2018 2.720 82 2924
2017 2.626 65 2900
2016 2.992 67 2743
2015 3.707 64 2760
2014 3.522 63 2629
2013 3.582 77 2528
2012 4.000 84 2521
2011 4.327 86 2094
2010 4.771 80 1973